Rocket Pharmaceuticals, Inc.
RCKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$258,746 | -$245,595 | -$221,863 | -$169,069 |
| Dep. & Amort. | $9,375 | $7,098 | $6,266 | $5,373 |
| Deferred Tax | $0 | $0 | $0 | $3,148 |
| Stock-Based Comp. | $43,920 | $39,406 | $31,009 | $29,237 |
| Change in WC | $1,919 | $13,458 | $6,076 | -$3,386 |
| Other Non-Cash | -$6,192 | -$9,283 | $370 | $13,534 |
| Operating Cash Flow | -$209,724 | -$194,916 | -$178,142 | -$121,163 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,862 | -$16,472 | -$8,619 | -$7,715 |
| Net Acquisitions | $0 | $0 | $42,726 | $95 |
| Inv. Purchases | -$245,886 | -$390,920 | -$376,327 | -$245,875 |
| Inv. Sales/Matur. | $383,454 | $309,326 | $272,894 | $272,443 |
| Other Inv. Act. | $0 | $0 | $0 | -$95 |
| Investing Cash Flow | $131,706 | -$98,066 | -$69,326 | $18,853 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $139 | $172 | $201 |
| Stock Issued | $185,739 | $208,394 | $155,335 | $37,681 |
| Stock Repurch. | $0 | $0 | -$47 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$132 | -$172 | -$201 |
| Financing Cash Flow | $185,739 | $208,401 | $155,288 | $37,681 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $107,721 | -$84,581 | -$92,180 | -$64,629 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $57,276 | $141,857 | $234,037 | $298,666 |
| End Cash | $164,997 | $57,276 | $141,857 | $234,037 |
| Free Cash Flow | -$215,586 | -$211,388 | -$186,761 | -$128,878 |